Publikationen Toxikologie

Name: Golka, K.): Leitlinienprogramm Onkologie. S3-Leitlinie Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms, Kurzversion 5.0 – September 2024 AWMF-Registernummer: 043-017OL (107 S.) Berlin: Office des Leitlinienprogrammes Onkologie, 2024
Author: Deutsche Krebsgesellschaft (Mitarb. u.a.

González D, Campos G, Pütter L, Friebel A, Holland CH, Holländer L, Ghallab A, Hobloss Z, Myllys M, Hoehme S, Meindl-Beinker NM, Dooley S, Marchan R, Weiss TS, Hengstler JG, Godoy P:

Role of WISP1 in stellate cell migration and liver fibrosis. Cells 13 (19): 1629 (2024) (15 pp)

El Naggar I, Cleaveland R, Panzer A, Molenaar S, Giorgi L, Wendel EM, Bertolini A, Karenfort M, Thiels C, Libá Z, Baumann M, Leiz S, Della Marina A, Hengstler JG, Deiva K, Neuteboom R, Reindl M, Rostásy K, BIOMARKER study group:

Long-term follow-up MR imaging in children with transverse myelitis. Mult Scler Relat Disord 92: 105926 (2024) (8 pp)

Owonikoko WM, Alimba CG:

Heavy metal contamination of the Nigerian environment from e-waste management: A systematic review of exposure pathway and attendant pathophysiological implications. Toxicology 509: 153966 (2024) (13 pp)

Boot IWA, Wesselius A, Jochems SHJ, Yu EYW, Bosetti C, Taborelli M, Porru S, Carta A, Golka K, Jiang X, Stern MC, Kellen E, Pohlabeln H, Tang L, Karagas MR, Zhang Z-F, Taylor JA, La Vecchia C, Zeegers MP:

Fruits and vegetables intake and bladder cancer risk: a pooled analysis from 11 case–control studies in the BLadder cancer Epidemiology and Nutritional Determinants (BLEND) consortium. Eur J Nutr 63: 2477–2498 (2024)

Deutsche Krebsgesellschaft (Mitarb. u.a.:

Golka, K.): Leitlinienprogramm Onkologie. S3-Leitlinie Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms, Kurzversion 5.0 – September 2024 AWMF-Registernummer: 043-017OL (107 S.) Berlin: Office des Leitlinienprogrammes Onkologie, 2024

Deutsche Krebsgesellschaft (Mitarb. u.a.:

Golka, K.): Leitlinienprogramm Onkologie. S3-Leitlinie Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms, Langversion 5.0 – September 2024 AWMF-Registernummer: 043-017OL (312 S.) Berlin: Office des Leitlinienprogrammes Onkologie, 2024

Selinski S, Ickstadt K, Golka K:

Modulating genetic effects on bladder cancer risk in an area of coal, iron, and steel industries. In: Weihs C, Krämer W, Buschfeld S (eds.): Statistics today. Everyday applications, research questions, insights, and challenges (pp 45-53). Berlin: Springer, 2024

Invernizzi A, Renzetti S, van Thriel C, Rechtman E, Patrono A, Ambrosi C, Mascaro L, Corbo D, Cagna G, Gasparotti R, Reichenberg A, Tang CY, Lucchini RG, Wright RO, Placidi D, Horton MK:

COVID-19 related cognitive, structural and functional brain changes among Italian adolescents and young adults: a multimodal longitudinal case-control study. Transl Psychiatry 14 (1): 402 (2024) (10 pp)

Alwahsh M, Hamadneh Y, Marchan R, Dahabiyeh LA, Alhusban AA, Hasan A, Alrawabdeh J, Hergenröder R, Hamadneh L:

Glutathione and xanthine metabolic changes in tamoxifen resistant breast cancer cell lines are mediated by down-regulation of GSS and XDH and correlated to poor prognosis. J Cancer 15: 4047-4058 (2024)

Hatten H, Colyn L, Volkert I, Gaßler N, Lammers T, Hofmann U, Hengstler JG, Schneider KM, Trautwein C:

Loss of Toll-like receptor 9 protects from hepatocellular carcinoma in murine models of chronic liver disease. Biochim Biophys Acta Mol Basis Dis 1870 (7): 167321 (2024) (10 pp)